Tenofovir Disoproxil Fumarate Intermediates
+
  • Tenofovir Disoproxil Fumarate Intermediates

Tenofovir Disoproxil Fumarate Intermediates

CAS No.:147127-20-6

Still deciding? Get samples first,  Contact US !

View similar products

Tag list

  • Product description
  • Product name:Tenofovir Disoproxil Fumarate Intermediates
    CAS No.:147127-20-6
    Structure:

    Tenofovir intermediate CAS 202138-50-9
    Appearance:White powdery solid
    Content:≥ 99.0%
    Packaging:Cardboard bucket

     

    Tenofovir Disoproxil Fumarate Intermediates are key components in the drug synthesis process.

    1. Chemical properties

    Structural complexity

    Tenofovir Disoproxil Fumarate Intermediates have a unique and complex chemical structure and are an important cornerstone for the construction of tenofovir disoproxil fumarate molecules. Its molecular structure contains specific functional groups and chemical bonds, and these structural features determine their activity and selectivity in subsequent reactions.

    Stability

    Under appropriate storage conditions, it has a certain chemical stability. However, in a specific reaction environment, it can react according to the expected chemical path. This balance between stability and reactivity is crucial for drug synthesis.

    2. Role in drug synthesis

    The key to the synthesis step

    It is an indispensable link in the synthesis of tenofovir disoproxil fumarate. They participate in a series of chemical reactions, such as substitution reactions, condensation reactions, etc., and gradually build the framework of the target drug molecule.

    Quality impact

    The quality of the intermediate directly affects the quality of the final tenofovir disoproxil fumarate. High-purity intermediates help reduce the introduction of impurities, thereby improving the safety and effectiveness of drugs.

    3. Application areas

    Pharmaceutical industry

    Mainly used in the production of drugs for diseases such as AIDS and hepatitis B. Tenofovir disoproxil fumarate is an important drug ingredient for the treatment of these diseases, and the stable supply and high quality of intermediates ensure the large-scale production of related drugs.

    Pharmaceutical research and development

    In the process of new drug research and development, Tenofovir Disoproxil Fumarate Intermediates also provide basic materials for researchers to explore new dosage forms and new ways of administration of drugs, which helps to promote the continuous development of pharmaceutical science.

ABOUT FUERTAI

Building A Pharmaceutical Enterprise That Meets International Standards

 

Huangshi Fuertal Pharmaceutical Technology Co., Ltd. was established on July 19, 2013, located in the Biomedical Park of Xisaishan Industrial Park in Huangshi City. It covers an area of 56000 square meters, has a registered capital of 30 million yuan, a total investment of 150 million yuan, and a designed annual production capacity of 6500 tons. The company is mainly engaged in the research and development, production, and sales of antiviral drug Tenofovir and related intermediates. The company currently has 150 employees, including 22 full-time staff in the technology research and development center, and employs 4 technical consultants with doctoral and master's degrees.

Factory environment
Factory environment
Factory environment
Factory environment

Keyword:

Tenofovir Disoproxil Fumarate Intermediates

CAS No.:147127-20-6

Still deciding? Get samples first,  Contact US !

Share to

Inquire Now

We will contact you within one working day. Please pay attention to your email.